| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
National Cancer Institute, Bethesda, Maryland; Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University, Durham; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham; Department of Radiology, Duke University Medical Center, Durham, North Carolina; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; and Department of Pathology, Duke University Medical Center, Durham, North Carolina
The purpose of this study was to confirm with pathologic verification 2 beliefs related to Alzheimer's disease (AD): (a) the long-standing impression that bilateral temporo-parietal hypometabolism, as noted on FDG PET imaging, is the metabolic abnormality associated with Alzheimer's disease (AD) and (b) that the sensitivity, specificity, and diagnostic accuracy of the metabolic pattern of bilateral temporo-parietal hypometabolism allows differentiation between other degenerative causes of dementia. Methods: Twenty two individuals (8 women, 14 men) with difficult-to-characterize memory loss or dementia (using standard clinical criteria), and who eventually received pathologic confirmation of diagnosis, were evaluated. FDG PET brain scans were obtained and visually graded by an experienced nuclear medicine physician as to the presence of classic bilateral temporo-parietal hypometabolism as seen in Alzheimer's type dementia. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of the metabolic pattern of bilateral temporo-parietal hypometabolism were determined using pathologic diagnosis as the gold standard. Results: The clinical diagnosis of possible or probable AD was determined as the primary cause of dementia in 12 patients. The sensitivity and specificity of the clinical diagnosis for probable AD were 63% and 100%, respectively. The sensitivity and specificity of the clinical diagnosis for possible and probable AD were 75% and 100%, respectively. The sensitivity, specificity, and diagnostic accuracy of bilateral temporo-parietal hypometabolism being associated with AD were 93%, 63%, and 82%, respectively. Conclusion: This study confirms that bilateral temporo-parietal hypometabolism is indeed the classic metabolic abnormality associated with AD. Furthermore, in individuals with dementia whose FDG PET scans indicated a metabolic pattern other than bilateral temporo-parietal hypometabolism, a cause of dementia other than AD should be suspected. These observations may be of clinical importance in differentiating dementia syndromes. The sensitivity, specificity, and diagnostic accuracy of FDG PET are acceptable as tests to be used in the evaluation of dementia and particularly to confirm the clinical suspicion of AD.
Key Words: dementia • FDG PET • Alzheimer's disease
Received May 3, 1999; revision accepted Mar. 2, 2000.
For correspondence or reprints contact: John M. Hoffman, MD, National Cancer Institute NCI/DCTD/DIP EPN/800, Diagnostic Imaging Program, 6130 Executive Blvd., MSC 7440, Bethesda, MD 20892-7440.
Related articles in JNM:
This article has been cited by other articles:
|
|
 |
|
  G. B. Fox, C.-L. Chin, F. Luo, M. Day, and B. F. Cox Translational NeuroImaging of the CNS: Novel Pathways to Drug Development Mol. Interv., December 1, 2009; 9(6): 302 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Hammoud, J. M. Hoffman, and M. G. Pomper Molecular Neuroimaging: From Conventional to Emerging Techniques Radiology, October 1, 2007; 245(1): 21 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Foster, J. L. Heidebrink, C. M. Clark, W. J. Jagust, S. E. Arnold, N. R. Barbas, C. S. DeCarli, R. Scott Turner, R. A. Koeppe, R. Higdon, et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease Brain, October 1, 2007; 130(10): 2616 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Jagust, B. Reed, D. Mungas, W. Ellis, and C. DeCarli What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology, August 28, 2007; 69(9): 871 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ishii, T. Soma, A. K. Kono, K. Sofue, N. Miyamoto, T. Yoshikawa, E. Mori, and K. Murase Comparison of Regional Brain Volume and Glucose Metabolism Between Patients with Mild Dementia with Lewy Bodies and Those with Mild Alzheimer's Disease J. Nucl. Med., May 1, 2007; 48(5): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Kulasingam, G. P. Samsa, and D. B. Matchar Linking dementia research to policy: An example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment American Journal of Alzheimer's Disease and Other Dementias, March 1, 2006; 21(2): 73 - 78. [PDF]
|
|
|
|
|
|
I. Prohovnik, D. P. Perl, K. L. Davis, L. Libow, G. Lesser, and V. Haroutunian Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease Neurology, January 10, 2006; 66(1): 49 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Scarmeas, C G Habeck, J Hilton, K E Anderson, J Flynn, A Park, and Y Stern APOE related alterations in cerebral activation even at college age J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1440 - 1444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H.S. Silverman Brain 18F-FDG PET in the Diagnosis of Neurodegenerative Dementias: Comparison with Perfusion SPECT and with Clinical Evaluations Lacking Nuclear Imaging J. Nucl. Med., April 1, 2004; 45(4): 594 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Patwardhan, D. C. McCrory, D. B. Matchar, G. P. Samsa, and O. T. Rutschmann Alzheimer Disease: Operating Characteristics of PET-- A Meta-Analysis Radiology, April 1, 2004; 231(1): 73 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rasgon and L. Jarvik Insulin Resistance, Affective Disorders, and Alzheimer's Disease: Review and Hypothesis J Gerontol A Biol Sci Med Sci, February 1, 2004; 59(2): M178 - M183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Scarmeas, E. Zarahn, K. E. Anderson, L. S. Honig, A. Park, J. Hilton, J. Flynn, H. A. Sackeim, and Y. Stern Cognitive Reserve-Mediated Modulation of Positron Emission Tomographic Activations During Memory Tasks in Alzheimer Disease Arch Neurol, January 1, 2004; 61(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Norfray and J. M. Provenzale Alzheimer's Disease: Neuropathologic Findings and Recent Advances in Imaging Am. J. Roentgenol., January 1, 2004; 182(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Knopman, B. F. Boeve, and R. C. Petersen Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308. [Abstract] [PDF]
|
|
|
|
|
|
P. M. McMahon, S. S. Araki, E. A. Sandberg, P. J. Neumann, and G. S. Gazelle Cost-Effectiveness of PET in the Diagnosis of Alzheimer Disease Radiology, August 1, 2003; 228(2): 515 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Boxer, K. P. Rankin, B. L. Miller, N. Schuff, M. Weiner, M.-L. Gorno-Tempini, and H. J. Rosen Cinguloparietal Atrophy Distinguishes Alzheimer Disease From Semantic Dementia Arch Neurol, July 1, 2003; 60(7): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Scarmeas, E. Zarahn, K. E. Anderson, C. G. Habeck, J. Hilton, J. Flynn, K. S. Marder, K. L. Bell, H. A. Sackeim, R. L. Van Heertum, et al. Association of Life Activities With Cerebral Blood Flow in Alzheimer Disease: Implications for the Cognitive Reserve Hypothesis Arch Neurol, March 1, 2003; 60(3): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H.S. Silverman and G. W. Small Prompt Identification of Alzheimer's Disease With Brain PET Imaging of a Woman With Multiple Previous Diagnoses of Other Neuropsychiatric Conditions Am J Psychiatry, September 1, 2002; 159(9): 1482 - 1488. [Full Text] [PDF]
|
|
|
|
|
|
D. H.S. Silverman, S. S. Gambhir, H.-W. C. Huang, J. Schwimmer, S. Kim, G. W. Small, J. Chodosh, J. Czernin, and M. E. Phelps Evaluating Early Dementia With and Without Assessment of Regional Cerebral Metabolism by PET: A Comparison of Predicted Costs and Benefits J. Nucl. Med., February 1, 2002; 43(2): 253 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Herholz, H. Schopphoff, M. Schmidt, R. Mielke, W. Eschner, K. Scheidhauer, H. Schicha, W.-D. Heiss, and K. Ebmeier Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer's Disease J. Nucl. Med., January 1, 2002; 43(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. S. Silverman, G. W. Small, C. Y. Chang, C. S. Lu, M. A. K. de Aburto, W. Chen, J. Czernin, S. I. Rapoport, P. Pietrini, G. E. Alexander, et al. Positron Emission Tomography in Evaluation of Dementia: Regional Brain Metabolism and Long-term Outcome JAMA, November 7, 2001; 286(17): 2120 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Bonte, M. F. Weiner, E. H. Bigio, C. L. White III, J. M. Hoffman, and R. E. Coleman SPECT Imaging in Dementias J. Nucl. Med., July 1, 2001; 42(7): 1131 - 1133. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Knopman, S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, G. W. Small, B. Miller, and J. C. Stevens Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, May 8, 2001; 56(9): 1143 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
D. H.S. Silverman and M. E. Phelps Evaluating Dementia Using PET: How Do We Put into Clinical Perspective What We Know to Date? J. Nucl. Med., November 1, 2000; 41(11): 1929 - 1932. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
